Diagnomitra’s Extended Heart Care package focuses on a detailed lipid analysis that goes beyond the standard cholesterol check. It helps detect hidden cardiovascular risks by analyzing the quality, size, and ratio of your lipids — essential for anyone aiming to prevent heart disease, manage cholesterol treatment, or track the effects of lifestyle changes.
Original price was: ₹1,650.00.₹1,402.50Current price is: ₹1,402.50.
Heart disease in India often strikes younger adults, with nearly 25% of heart attacks occurring under age 40 (AIIMS Cardiology Review, 2024). The major culprit? Abnormal lipid patterns that traditional tests often miss.
A basic lipid test measures total cholesterol, HDL, LDL, and triglycerides. But that’s just the surface. The Extended Heart Care package offers a deeper lipid profile, assessing additional sub-fractions and ratios that reveal your true cardiac risk.
Even if your total cholesterol appears normal, you might still have small, dense LDL particles that are highly atherogenic (more likely to clog arteries). This package helps identify those hidden dangers early, allowing timely dietary or medical intervention.
The Extended Lipid Profile in this package typically covers:
| Test | Full Name | Diagnostic Purpose |
|---|---|---|
| Total Cholesterol | Overall cholesterol in your blood. | |
| HDL Cholesterol | “Good cholesterol” that removes LDL from arteries. | |
| LDL Cholesterol (Direct) | “Bad cholesterol” — elevated levels increase plaque buildup risk. | |
| VLDL Cholesterol | Carries triglycerides; high levels indicate metabolic imbalance. | |
| Triglycerides | Type of fat from food and excess calories; linked to heart and liver disease. | |
| Non-HDL Cholesterol | Combined measure of all bad cholesterol types; superior predictor of heart risk. | |
| TC/HDL & LDL/HDL Ratios | Key risk ratios used globally to assess overall cardiac threat. |
Together, these metrics allow a far more accurate evaluation of your heart risk profile — particularly useful for individuals whose standard lipid tests look “normal” but still experience borderline or resistant cardiovascular risk.
A deeper lipid assessment is crucial for:
Diabetes or pre-diabetes patients, where triglyceride and HDL patterns can mask heart risk.
People with family history of high cholesterol or premature heart attacks.
Individuals on statins or lifestyle therapy, to monitor real lipid particle improvement, not just surface-level totals.
Overweight individuals or those with fatty liver, PCOS, or thyroid imbalances.
This package helps doctors identify residual risk — that hidden gap between your lab values and your actual cardiovascular condition. With these insights, treatment can be personalized for diet, exercise, or medication.
You should opt for the Extended Heart Care package if you:
Have already done a basic lipid test but need a more refined breakdown.
Are under preventive cardiac therapy and want to assess medication response.
Are over 35 years old or have sedentary habits, stress, or mild hypertension.
Have borderline cholesterol despite eating well and exercising — to understand why.
Doctors typically recommend repeating this profile every 6–12 months for patients under cardiac monitoring or those with a family history of heart issues.
Diagnomitra’s Extended Lipid testing uses automated high-precision biochemistry analyzers and standardized NABL-accredited protocols for reproducibility and accuracy.
Detailed subfraction analysis beyond conventional lipid counts.
AI-assisted interpretation highlighting key ratios and risk categories.
Home collection available across Indian cities, including Agra, Lucknow, and Delhi NCR.
Reports within 24–36 hours with optional teleconsultation to interpret results.
Our mission: to move from basic detection to precision prevention — giving you the data you need to protect your heart intelligently.
The Extended Heart Care package provides a deeper, more diagnostic lipid profile than basic cholesterol tests.
Helps detect hidden cardiac risks like small, dense LDL or abnormal lipid ratios.
Ideal for preventive screening, therapy monitoring, and high-risk individuals.
Conducted in NABL-accredited Diagnomitra labs with accurate, detailed reports.
Recommended every 6–12 months to track heart health and refine prevention strategies.
John Doe
Codetic
Add testimonial description here. Edit and place your own text.
John Doe
Codetic
Add testimonial description here. Edit and place your own text.
John Doe
Codetic
Add testimonial description here. Edit and place your own text.